The estimated Net Worth of John Demaree is at least $5.55 Tisíc dollars as of 26 August 2020. John Demaree owns over 7,500 units of Karyopharm Therapeutics Inc stock worth over $5,550 and over the last 6 years John sold KPTI stock worth over $0.
John has made over 2 trades of the Karyopharm Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently John bought 7,500 units of KPTI stock worth $109,050 on 26 August 2020.
The largest trade John's ever made was buying 7,500 units of Karyopharm Therapeutics Inc stock on 26 August 2020 worth over $109,050. On average, John trades about 1,214 units every 89 days since 2018. As of 26 August 2020 John still owns at least 7,500 units of Karyopharm Therapeutics Inc stock.
You can see the complete history of John Demaree stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON, MA, 02459.
Over the last 11 years, insiders at Karyopharm Therapeutics Inc have traded over $149,223,596 worth of Karyopharm Therapeutics Inc stock and bought 562,763 units worth $10,312,371 . The most active insiders traders include Deepika Pakianathan, Ltd Czernik Marcin Hadjimic... a Mikael Dolsten. On average, Karyopharm Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $26,350. The most recent stock trade was executed by Michael Mano on 4 September 2024, trading 3,971 units of KPTI stock currently worth $2,859.
karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com
Karyopharm Therapeutics Inc executives and other stock owners filed with the SEC include: